Skip to main content

Advertisement

SpringerLink
Log in

Well-Differentiated Thyroid Carcinoma with Concomitant Hashimoto’s Thyroiditis Present with Less Aggressive Clinical Stage and Low Recurrence

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) are the most common differentiated thyroid cancers. Previous studies report that Hashimoto’s thyroiditis (HT) concomitant with PTC is unusual and improves prognosis compared to classical PTC. Few previous studies address FTC concomitant with HT. In this study, we retrospectively analyzed data from one institution and compared clinical presentations and results of treatment of PTC and FTC with and without HT. In addition, studies comparing presentation and long term follow-up prognosis in classical PTC and FTC were conducted. A total of 1,788 PTC patients and 209 FTC patients underwent thyroidectomy with or without lymph node dissection and follow-up at Chang Gung Medical Center in Linkou, Taiwan. All thyroid carcinomas were pathologically classified according to World Health Organization criteria. Histological patterns of PTC were categorized as classical PTC, or PTC with HT. Follicular thyroid carcinoma patients were categorized as FTC or FTC with HT. The dataset contained a total of 1,703 PTC cases categorized as classical PTC, 85 cases of PTC with HT, 201 cases of FTC and eight cases of FTC with HT. Analysis of Classification of Malignant Tumors (TNM) stage revealed a higher percentage of classical PTC in stage IV than HT group (12.03% vs. 4.70%). Mean tumor size of classical PTC was larger than HT group. Although 42.3% of FTC cases presented with distant metastases, no cases of FTC with HT presented with distant metastasis. Cancer-specific mortality was higher in classical PTC group than in PTC with HT. There was 53.2% of FTC without HT assigned recurrent status, and six of them died of thyroid cancer. No cancer mortality or recurrence in HT with FTC. PTC and FTC with HT presented with better clinical stage and better prognosis after same therapeutic modality. In conclusions, both PTC and FTC with HT have less aggressive clinical presentation and better prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84:458–63, 1999.

    Article  PubMed  CAS  Google Scholar 

  2. Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer. J Surg Res 150:49–52, 2008.

    Article  PubMed  Google Scholar 

  3. Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 71:874–8, 2005.

    PubMed  Google Scholar 

  4. Del Rio P, Cataldo S, Sommaruga L, Concione L, Arcuri MF, Sianesi M. The association between papillary carcinoma and chronic lymphocytic thyroiditis: does it modify the prognosis of cancer? Minerva Endocrinol 33:1–5, 2008.

    PubMed  Google Scholar 

  5. Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, Hong SJ, Gong G, Shong YK. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol 71:581–6, 2009.

    Article  Google Scholar 

  6. Liu FH, Chang HY, Huang BY, Liou MJ, Hsueh C, Lin JD. Sonography and fine-needle aspiration biopsy in the diagnosis of benign versus malignant nodules in patients with autoimmune thyroiditis. J Clin Ultrasound 37:487–92, 2009.

    Article  PubMed  Google Scholar 

  7. Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto’s disease of the thyroid gland. Arch Surg 70:291–7, 1955.

    CAS  Google Scholar 

  8. Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K, Tamai H. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 80:3421–4, 1995.

    Article  PubMed  CAS  Google Scholar 

  9. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414–24, 1990.

    Article  PubMed  CAS  Google Scholar 

  10. Woolner LB, McConaley WM, Beahrs OH. Struma lymphomatosa (Hashimoto’s thyroiditis) and related thyroid disorders. J Clin Endocrinol Metab 19:53–83, 1959.

    Article  PubMed  CAS  Google Scholar 

  11. Sobin LH. UICC. Wittekind Ch (eds.) TNM classification of malignant tumors, 6th edition. Wiley, New York, 2002: pp. 52–56.

    Google Scholar 

  12. DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of endocrine organs. Lyon: IARC; 2004.

    Google Scholar 

  13. Lin JD, Lin KJ, Chao TC, Hsueh C, Tsang NM. Therapeutic outcome of papillary thyroid carcinoma advance than T1N0M0. Radiother Oncol 89: 97–104, 2008.

    Article  PubMed  Google Scholar 

  14. Zhang DD, Zhou XH, Freeman DH, Freeman JL. A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Stat Med 21:701–15, 2002.

    Article  PubMed  Google Scholar 

  15. Kamma H, Fujii K, Ogata T. Lymphocytic infiltration in juvenile thyroid carcinoma. Cancer 62:1988–93, 1988.

    Article  PubMed  CAS  Google Scholar 

  16. Okayasu I, Saegusa M, Fujiwara M, Hara Y, Rose NR. Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma. J Cancer Res Clin Oncol 121:746–52, 1995.

    Article  PubMed  CAS  Google Scholar 

  17. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 76:2312–8, 1995.

    Article  PubMed  CAS  Google Scholar 

  18. Anil C, Goksel S, Gursoy A. Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid 20: 601–6, 2010.

    Article  PubMed  Google Scholar 

  19. Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 27:2977–82, 2009.

    Article  PubMed  CAS  Google Scholar 

  20. Kim TY, Kim WB, Rhee YS, Song JY, Kim JM, Gong G, Lee S, Kim SY, Kim SC, Hong SJ, Shong YK. The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clin Endocrinol 65:364–8, 2006.

    Article  CAS  Google Scholar 

  21. Kim SK, Song KH, Lim SD, Lim YC, Yoo YB, Kim JS, Hwang TS. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid 19:137–41, 2009.

    Article  PubMed  Google Scholar 

  22. Tamimi DM. The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol 10:141–6, 2002.

    Article  PubMed  Google Scholar 

  23. Russell JP, Engiles JB, Rothstein JL. Proinflammatory mediators and genetic background in oncogene mediated tumor progression. J Immunol 172:4059–67, 2004

    PubMed  CAS  Google Scholar 

  24. Mardente S, Zicari A, Consorti F, Mari E, Di Vito M, Leopizzi M, Della Rocca C, Antonaci A. Cross-talk between NO and HMGB1 in lymphocytic thyroiditis and papillary thyroid cancer. Oncol Rep 24:1455–61, 2010.

    Article  PubMed  CAS  Google Scholar 

  25. Huang CC, Hsueh C, Liu FH, Chao TC, Lin JD. Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas. Surg Oncol 20:1–6, 2011.

    Article  PubMed  Google Scholar 

  26. Lin JD, Chao TC, Chen ST, Huang YY, Liou MJ, Hsueh C. Operative strategy of follicular thyroid cancer in different risk groups using pTNM staging. Surg Oncol 16:107–37, 2007.

    Article  PubMed  Google Scholar 

  27. McKee RF, Krukowski ZH, Matheson NA. Thyroid neoplasia coexistent with chronic lymphocytic thyroiditis. Br J Surg 80:1303–4, 1993.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Keelung and Linkou Chang Gung Memorial Hospitals, Chang Gung University, 5, Fu-Shin St. Kweishan county, Taoyuan Hsien, Taiwan, Republic of China

    Bie-Yu Huang & Jen-Der Lin

  2. Department of Pathology, Chang Gung University, Taiyuan, Taiwan, Republic of China

    Chuen Hseuh

  3. Department of General Surgery, Chang Gung University, Taiyuan, Taiwan, Republic of China

    Tzu-Chieh Chao

  4. Department of Nuclear Medicine, Chang Gung Memorial Hospital, Chang Gung University, Taiwan, Republic of China

    Kun-Ju Lin

Authors
  1. Bie-Yu Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chuen Hseuh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tzu-Chieh Chao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kun-Ju Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jen-Der Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jen-Der Lin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, BY., Hseuh, C., Chao, TC. et al. Well-Differentiated Thyroid Carcinoma with Concomitant Hashimoto’s Thyroiditis Present with Less Aggressive Clinical Stage and Low Recurrence. Endocr Pathol 22, 144–149 (2011). https://doi.org/10.1007/s12022-011-9164-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-011-9164-9

Keywords

Search

Navigation